Cytori Therapeutics (CYTX) Get U.S. FDA 501(k) Marketing Clearance for PureGraft System

January 8, 2010 8:30 AM EST Send to a Friend
The FDA has granted Cytori Therapeutics (NASDAQ: CYTX) 510(k) marketing clearance for its PureGraft System. Cytori will now launch the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login